Cost-effectiveness of preoperative autologous blood donation for orthopedic and cardiac surgeries

https://doi.org/10.1016/S0002-9343(96)00163-5Get rights and content

Decision analysis techniques can be used to determine objectively the health improvement benefit obtained from a medical intervention relative to the resources required for the intervention. Such calculations can help direct societal healthcare policies but may not be directly applicable to an individual patient. However, these analyses can still be used to indicate those situations in which an intervention is most beneficial and those in which its use may not be appropriate. Preoperative autologous blood donation (PABD), for example, may not be cost-effective if blood units are collected when they are not likely to be used or if such units are transfused solely because they are available. Furthermore, the risks associated with PABD may exceed those of the allogeneic transfusion that the patient seeks to avoid, particularly in patients with significant cardiac disease. In such settings, careful, objective analyses may help direct not only healthcare policy but also hemotherapy practice for individual patients.

References (11)

  • EisenbergJM

    Clinical economics: a guide to the economic analysis of clinical practices

    JAMA

    (1989)
  • WeinsteinMC et al.

    Foundation of cost-effectiveness analysis for health and medical practices

    N Engl J Med.

    (1977)
  • BirkmeyerJD et al.

    The cost-effectiveness of preoperative autologous donation in coronary bypass surgery

    Ann Thorac Surg.

    (1994)
  • GoodnoughLT et al.

    The variability of transfusion practice in coronary artery bypass surgery

    JAMA

    (1991)
  • EtchasonJ et al.

    The cost effectiveness of preoperative autologous blood donations

    N Engl J Med.

    (1995)
There are more references available in the full text version of this article.

Cited by (19)

  • Anesthesia for liver resection and transplantation

    2004, EMC - Anesthesie-Reanimation
  • Prevalence and outcomes of anemia in surgery: A systematic review of the literature

    2004, American Journal of Medicine
    Citation Excerpt :

    However, autologous blood transfusion may provide cost savings in the form of a reduced incidence of complications.60 Because a large proportion of the autologous blood that is collected is never used,3 cost savings may be even greater if autologous blood is donated only by the patients most likely to need transfusion.61 Other preoperative management techniques, such as the more widespread use of epoetin therapy without autologous blood donation, may also prove cost-effective.

  • New transfusion strategies

    1997, American Journal of Surgery
  • Development of a Patient Blood Management Programme

    2022, Practical Transfusion Medicine: Sixth Edition
View all citing articles on Scopus
View full text